A smoking cessation intervention with hospitalized surgical cancer patients: a pilot study.
The purpose of this pilot study was to examine the effect of a structured smoking cessation intervention during hospitalization on short-term smoking abstinence. Hospitalized surgical oncology patients who smoked (n = 26) and were diagnosed with cancer were randomly assigned to either an experimental or control group. Experimental group subjects (n = 12) received a structured smoking cessation intervention during hospitalization followed by five weekly phone calls after discharge. Control group subjects (n = 14) received usual care from their health-care providers during hospitalization. Abstinence from smoking, as determined by saliva cotinine, the primary metabolite of nicotine, was measured at first postdischarge visit. Subjects with a saliva cotinine level of < 10 ng/ml were classified as abstinent. At first postdischarge visit, 75% of experimental group subjects were abstinent compared with 42.9% in the usual care group, a 32% difference. These preliminary findings will assist in the design and further evaluation of cancer rehabilitation strategies promoting cessation in hospitalized postoperative cancer patients who continue to smoke.
Stanislaw
A E
AE
Marymount Hospital, Garfield Heights, Ohio.
Wewers
M E
ME
D000328:Adult; D000368:Aged; D003367:Cotinine / Q000032:analysis; D005260:Female; D006801:Humans; D007297:Inpatients; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000451:nursing / Q000601:surgery*; D010865:Pilot Projects; D012463:Saliva / Q000737:chemistry; D012907:Smoking / Q000378:metabolism; D016540:Smoking Cessation / Q000379:methods*; D000074606:Smoking Prevention
D003367:Cotinine